A Phase IIa Double-Blind Placebo-Controlled Clinical Trial Investigating the Efficacy and Safety of Arborvitae Health and Wellbeing Supplement in Improving Blood Glucose Levels in Pre-Diabetes Participants.
Pre-diabetes is defined as a condition in which blood glucose levels are elevated above the normal range but do not satisfy the criteria for the diagnosis of diabetes mellitus
Source: Twigg, S.M.; Kamp, M.C.; Davis, T.M.; Neylon, E.K.; Flack, J.R (2007) Prediabetes: A position statement from the Australian diabetes society and Australian diabetes educators association. The Medical Journal of Australia 186, 461-465.
Pre-diabetes affects about 16.4% of Australian adults. People with prediabetes are at increased risk of developing type 2 diabetes, and heart disease.
With current usage, prediabetes can be applied as a label for a disorder or as a risk category for diabetes and cardiovascular disease. There is no clear evidence which of these has greater clinical utility.
Source: Twigg S.M , Kamp M. C, Davis T, Neylon E.K, Flack J (2007) Prediabetes: a position statement from the Australian Diabetes Society and Australian Diabetes Educators Association. Med J Aust 2007; 186 (9): 461-465. || doi: 10.5694/j.1326-5377.2007.tb00998.x
This is an investigative study on the safety and efficacy of French Maritime Pine Bark Extract, Papain and Aloe Vera in pre-diabetic participants.